Radionuclide-Drug Conjugates (RDCs) Inhibitors

查看全部
Product Name RDC Peptide RDC Antibody RDC Bifunctional Chelator RDC Linker Other Purity
(R)-NODAGA-tris(t-Bu ester)
(S)-DOTAGA.(SA.FAPi)2
(S)-EB-FAPI-B2
(S)-NH2-NODAGA hydrochloride 99.91%
2,3,5,6-Tetrafluorophenyl propionate-PEG3-amino-tetraxetan
2-Aminoethyl-mono-amide-DOTA-tris(tBu ester) 98.0%
3BP-3940 99.49%
3p-C-NOTA
3P-RGD2
AKIR001
Aldoview
AlF-NOTA-c-d-VAP
Altumomab
Anditixafortide 99.99%
Azido-mono-amide-DOTA 99.96%
BCN-DOTA
BCN-DOTA-GA
BCN-NODAGA
BQ7859
BQ7876
Butyne-DOTA 97.50%
CD73-IN-22
Cetuximab (PBS) 99.33%
cFLFLF
cRY9M
cT84.66
CTB006
cTMTP1
Cyclic αvβ6
Cyprodenate 98.0%
Cys-FAP targeting peptide for FXX489
Cys-FAP targeting peptide for FXX489 TFA 95.77%
Deferoxamine-DBCO 89.08%
Depreotide
DOTA Conjugated JM#21 derivative 7
DOTA Zoledronate
DOTA(tBu3)-PEG4-TFP
DOTA-bis(tert-butyl)ester 99.25%
DOTA-Bombesin (1-14)
DOTA-Bombesin (1-14) TFA 98.10%
DOTA-BP1
DOTA-CA-170
DOTA-cTMTP1
DOTA-CXCR4-L
DOTA-cyclo(RGDfK) 99.53%
DOTA-EB-TATE 95.42%
DOTA-ECL1i 98.06%
DOTA-FAPT
DOTA-GA(tBu)4 98.69%
DOTA-GA-maleimide 99.72%
DOTA-GPC3 targeting peptide 2 98.83%
DOTA-JR11 99.14%
DOTA-Lanreotide
DOTA-LM3 99.37%
DOTA-LM3 TFA 99.25%
DOTA-NAPamide
DOTA-NOC 99.22%
DOTA-NT-20.3-IPBA
DOTA-Octreotide
DOTA-Octreotide TFA 99.50%
DOTA-PEG10-azide
DOTA-PEG4-TFP
DOTA-Pep-1L
DOTA-Pep-1L TFA 98.60%
DOTA-PSMA-EB-01 97.02%
DOTA-SMIC-1014
DOTA-TH10
DOTA-tri(t-butyl ester) 99.09%
DOTA-ubiquicidin (29–41)
DOTA.SA.FAPi TFA 99.26%
DOTAEt
DOTAGA-anhydride
DOTAGA-anhydride 99.80%
DOTAGA.Glu.(FAPi)2
DOTAM-mono-acid 98.35%
DOTAM-NHS-ester
DOTATATE 99.94%
DOTATATE acetate 99.95%
DP1 peptide
DPI-4452 99.30%
DTPA anhydride 97.0%
DTPA-tetra(tBu)ester 95.0%
EB-PSMA-617 96.38%
Edotreotide 98.71%
Ethylenediaminetetra(methylenephosphonic acid) sodium
FAP targeting peptide for FXX489 99.49%
FAP targeting peptide-PEG2 conjugate
FAPI-mFS 98.71%
Flotufolastat Ga
Fluorescein-triazole-PEG5-DOTA
Fluoroestradiol
Fmoc-D-Dap(Boc)-OH
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) 98.26%
Galacto-RGD
GB-6
Granzyme B contrast agent-1
Guraxetan-NH-PEG3-TFP ester
HQ-415 98.05%
HYF038
HYNIC-iPSMA
HYNIC-iPSMA TFA 98.05%
HYNIC-PSMA 98.67%
Hynic-toc
IPM-N001
JR11-PEG3-DOTA-PSMA-03
JR11-PEG3-HBED-CC-PSMA-03
Lu-AAZTA-NI-PSMA-093
MAIPGG
Maleimide-DTPA
Maleimide-NOTA 99.26%
Maleimide-NOTA TFA
MIP-1072
MIP-1095
MIP-1095 TFA 99.76%
MK-7337 98.14%
MMA-NODAGA
NCS-MP-NODA
NH-CH2-CH2-DOTAM
NH2 DOTA-GA 99.95%
NH2-NODAGA
NH2-NODAGA hydrochloride
NH2-NODAGA TFA
NH2-PEG4-DOTA 99.89%
NH2-PEG4-NODA-GA
NM404
NO2A-(t-Bu ester)
NO2A-Azide trihydrochloride 95.04%
NO2A-Butyne 98.0%
NO2A-Butyne-bis(t-Butyl ester)
NODAGA-LM3 99.65%
NODAGA-LM3 TFA
NODAGA-NHS
NOPO
NOTA 98.0%
NOTA trihydrochloride
NOTA-AE105 98.99%
NOTA-bis(tBu)ester 98.0%
NOTA-COG1410
NOTA-FAPI 99.66%
NOTA-FZCD-3
NOTA-NHS ester 90.0%
NOTA-Octreotide
NOTA-Pep-1L 98.60%
NOTA-PTP
NOTA-RHAU18
NOTA-SP2A-PSMAL
NOTP
NP1
NYM074
OI-3
p-NCS-Bz-NODA-GA 99.46%
p-NH2-Bn-NOTA hydrochloride hydrate 98.07%
p-SCN-Bn-deferoxamine 98.0%
p-SCN-Bn-DOTA 99.78%
p-SCN-Bn-HOPO 95.0%
p-SCN-Bn-NOTA trihydrochloride 99.75%
p-SCN-Macropa
PD151242
PDI2 99.00%
Pendetide
Pentixafor 99.60%
Polyamidoamine (20% in methanol)
Propargyl-DOTA-tris(tBu)ester
Propargyl-NOTA(tBu)2
ProX1-(SS)-DOTAGA
ProX1-(SS)-DOTAGA_R
PSMA-11 99.43%
PSMA-BCH 99.93%
PSMA-D5 98.61%
PTP peptide
Satoreotide 98.80%
SC691
SCN-PYTA
SDM-8 99.79%
SU015
TA-DOTA
TA-DOTA-GA
Tabituximab barzuxetan (exclude Y90)
TCO-GK-PEG4-NHS ester
Tecnemab K1
Tetraxetan 99.95%
THP(Bz)3-NH2
THP(Bz)3-NH2 TFA 91.15%
THP(Bz3)-Glu
TRAP
Tyr3-Octreotate 99.76%
Tyr3-Octreotate acetate 99.76%
Tz-Ph-PEG4-NH-DOTA
Tz-Ph-PEG4-NH-DOTA tetraTFA 98.01%
VCAM1 binding peptide
VHPKQHR
WL12 99.98%
α-Synuclein aggregate binder 1 98.11%
Butyne-DOTA-tris(t-butyl ester) 98.51%
Ethylenediaminetetra(methylenephosphonic acid) 99.9%
Rituximab 99.50%
Pentetreotide 98.13%
Trastuzumab 99.80%
Lintuzumab 98.09%
Rosopatamab 99.47%
Cetuximab 99.81%
Betiatide 98.72%

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础